JMAT.L $1 941.50 -0.0257%
NYC $8.23 -2.6367%
GRPH $3.06 -0.9709%
ALSO3.SA $19.40 0%
USAU $4.06 -2.4038%
2153.HK $1.30 -1.5152%
OCFCP $21.71 -0.6944%
AACQU $11.05 0%
3886.HK $0.30 1.6949%
GDIG.L $30.89 -0.1778%
PNL.L $478.00 -0.8299%
PCCT $11.41 5.5715%
OI $20.70 -0.9095%
GENY $40.69 -0.9761%
INBX $24.43 -2.5528%
0286.HK $0.50 -3.8462%
DSUS.L $89.74 0.4477%
IAPD.L $1 681.50 0.1191%
NVDE.L $120.07 1.1925%
QUBT $1.22 -3.5714%
INTB3.SA $25.32 0.2375%
KCCA $24.41 0.2876%
CLSC $19.31 -0.2294%
0396.HK $0.09 0%
1660.HK $0.36 2.8985%
WEAT $6.39 0.7098%
HCAN.L $1 664.00 0.0451%
IDAT $21.21 0.2018%
G07.SI $17.10 -0.5814%
PFO $7.34 0.2732%
ATYM.L $336.00 1.5106%
ENNV $7.63 0%
0499.HK $0.17 0%
0101.HK $12.96 -2.1148%
1856.HK $2.40 0%
AGNCM $20.80 -0.9524%
0QVW.L $10.05 -0.4951%
ITS.L $0.38 50%
GROM $0.44 -7.9975%
POSI3.SA $6.66 -16.75%
0UWL.L $14.45 -4.5575%
TXT $62.97 -2.266%
O32.SI $1.76 0%
VNRX $1.76 -6.6296%
2122.HK $0.08 8.2192%
9993.HK $3.79 -0.7853%
GSG $19.02 -0.705%
CMS-PC $18.63 0.6391%
ALDV.PA $0.06 -20%
CION $9.22 -2.1762%
NGVC $11.06 0.363%
BMK.L $40.69 -2.4221%
SBAC $233.73 0.2896%
2239.HK $2.20 0%
1191.HK $0.02 0%
EWI.L $149.00 -0.7989%
Q5T.SI $0.60 -2.459%
SESG.PA $5.93 1.89%
ABT $109.64 -0.3726%
GFHG.L $1.75 -41.6667%
WSBC $21.38 -0.9727%
FGM $38.05 -2.5399%
HMFD.L $47.24 0%
ESSCR $0.60 0%
HUBG $74.28 0.1078%
DGHI $1.55 -3.7267%
6988.HK $0.99 -1%
6117.HK $0.60 0%
MLSS $0.82 12.2446%
0RQI.L $7.77 0.5073%
NS-PB $22.29 0.0224%
ACA.PA $11.72 1.437%
AMS.MC $65.82 0.4885%
EMLDW $0.10 0%
ALLOG.PA $0.36 -1.0899%
WAND.L $1 310.00 0%
WPHO.L $8.00 0%
JFIN $5.52 2.9851%
8456.HK $0.22 0%
MTIG4.SA $28.00 0%
NC $31.70 0.9554%
CVEO $20.97 2.0935%
SYM.L $7.75 0%
8098.HK $0.06 0%
XMTD.L $46.96 -0.2231%
SOUN $2.43 -5.4436%
CENX $7.23 0.3472%
BB.PA $57.05 0%
PHAR $11.67 14.2997%
CMP $33.20 2.4768%
0770.HK $0.18 -8.80829%
AIHS $0.89 -3.0986%
6049.HK $42.05 0.119%
MCHI $46.15 -2.6887%
ALB $194.93 -1.8084%
CB $199.05 -1.1619%
NAV $44.50 0%
STRO $5.47 0.0916%
WIX $75.25 -3.0783%
Eng
Логотип
Eng
Лого

Pherecydes Pharma Société anonyme ALPHE.PA

$2.13

На 18:05, 12 мая 2023

Ключевые показатели

  • Marketcap

    17482590.00000000

  • week52high

    5.00

  • week52low

    1.86

  • Revenue

    2142291

  • P/E TTM

    -4

  • Beta

    0.85679600

  • EPS

    -0.51000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    07 мар 2023 г. в 14:00

Описание компании

Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек